Larvol Delta - Avenue-Therapeutics-Announces-First-Patient-Dosed-in-Phase-1b2a-Clinical-Trial-of-AJ201-for-the-Treatment-of-Spinal-and-Bulbar-Muscular-Atrophy-Kennedy39s-Disease

ALZ002 - AnnJi Pharma, Fortress

https://www.globenewswire.com/news-release/2023/07/27/2712191/0/en/Avenue-Therapeutics-Announces-First-Patient-Dosed-in-Phase-1b-2a-Clinical-Trial-of-AJ201-for-the-Treatment-of-Spinal-and-Bulbar-Muscular-Atrophy-Kennedy-s-Disease.html

Jul 27, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next